Eli Lilly and Company is discovering and developing new, innovative drug delivery systems and treatment technologies to realize our vision of improving global health into the 21st Century. Both at our Cambridge Innovation Center and at our corporate research facilities, we will leverage these anonymized datasets as we develop new delivery devices, algorithms and mobile medical applications, which will provide one with actionable insight for simpler, more effective diabetes management.